Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Wentao Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3332-8112; OpenAlex author ID A5063784705. Sources: OpenAlex.

Their work

Papers
33 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
71
Papers, trials and grants by year

2011: 3 papers · 2012: none · 2013: 3 papers · 2014: 3 papers · 2015: none · 2016: none · 2017: 5 papers · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 5 papers · 2022: 3 papers · 2023: 2 papers · 2024: none · 2025: 4 papers · 2026: 1 paper

Papers 33

  1. Long-term outcomes of upfront pancreatectomy with venous resection for pancreatic cancer: a single-center, retrospective analysis. Co-author DOI 10.1097/js9.0000000000003617↗
  2. Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting. Co-author DOI 10.1186/s12885-025-14601-2↗
  3. Editorial expression of concern: Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/… Co-author DOI 10.1186/s12943-025-02326-6↗
  4. Correction: A Yin-Yang 1/miR-30a regulatory circuit modulates autophagy in pancreatic cancer cells. Co-author DOI 10.1186/s12967-025-06581-5↗
  5. Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer. Co-author DOI 10.1200/jco.24.00287↗
  6. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway. Co-author DOI 10.1186/s13046-023-02792-0↗
  7. Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer. Last author DOI 10.21037/gs-23-24↗
  8. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Co-author DOI 10.1001/jamanetworkopen.2021.48721↗
  9. FTO deubiquitinated by USP7 influenced NEDD4 mRNA stability enhancing the chemoresistance of pancreatic cancer to gemcitabine by promoting cell proliferation a… Last author DOI 10.21203/rs.3.rs-1902113/v1↗
  10. Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma. Last author DOI 10.7717/peerj.12736↗
  11. Sub-adventitial divestment technique for resecting artery-involved pancreatic cancer: a retrospective cohort study. Co-author DOI 10.1007/s00423-021-02080-5↗
  12. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer. Last author DOI 10.1007/s10637-021-01114-5↗
  13. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-3021↗
  14. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer Last author DOI 10.21203/rs.3.rs-139597/v2↗
  15. CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.832315↗
  16. Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis. Co-author DOI 10.1007/s00268-019-05325-z↗
  17. [Comparison of radical antegrade modular pancreatosplenectomy with conventional distal pancreatectomy for pancreatic adenocarcinoma of the body and tail]. Co-author DOI 10.3760/cma.j.cn112139-20200413-00301↗
  18. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. Co-author DOI 10.1007/s00423-019-01766-1↗
  19. Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer. Co-author DOI 10.1186/s12876-018-0891-y↗
  20. Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase reg… Co-author DOI 10.1186/s12943-017-0619-6↗
  21. A Yin-Yang 1/miR-30a regulatory circuit modulates autophagy in pancreatic cancer cells. Co-author DOI 10.1186/s12967-017-1308-3↗
  22. PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer. Co-author DOI 10.1186/s13046-017-0500-x↗
  23. The clinical value, regulatory mechanisms, and gene network of the cancer-testis gene STK31 in pancreatic cancer. Co-author DOI 10.18632/oncotarget.16814↗
  24. MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma. Co-author DOI 10.3892/or.2017.6036↗
  25. Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction. Co-author DOI 10.1186/1471-2407-14-738↗
  26. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Co-author DOI 10.1186/1476-4598-13-130↗
  27. Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the … Co-author DOI 10.1186/s12967-014-0309-8↗
  28. MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. Co-author DOI 10.1016/j.canlet.2012.11.005↗
  29. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric … Co-author DOI 10.1186/1479-5876-11-262↗
  30. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Co-author DOI 10.3892/ijo.2013.2015↗
  31. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12032-010-9683-0↗
  32. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. Co-author DOI 10.1016/s1499-3872(11)60014-3↗
  33. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an i… Co-author DOI 10.1097/mpa.0b013e318217945e↗

Closest collaborators

The 25 strongest of 71 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kuirong Jiang · 24 shared papers, 2011–2026 · strength 2.38
  2. Junli Wu · 18 shared papers, 2011–2026 · strength 1.83
  3. Jishu Wei · 17 shared papers, 2011–2025 · strength 1.66
  4. Yi Miao · 19 shared papers, 2011–2025 · strength 1.58
  5. Min Tu · 12 shared papers, 2013–2026 · strength 1.55
  6. Yunpeng Peng · 10 shared papers, 2013–2025 · strength 1.07
  7. Zipeng Lu · 10 shared papers, 2011–2026 · strength 1.04
  8. Lingdi Yin · 8 shared papers, 2017–2025 · strength 0.98
  9. Jingjing Zhang · 8 shared papers, 2013–2025 · strength 0.60
  10. Chaozhi Yang · 4 shared papers, 2021–2022 · strength 0.58
  11. Chenjie Qiu · 4 shared papers, 2021–2022 · strength 0.52
  12. Kai Lin · 3 shared papers, 2021–2023 · strength 0.48
  13. Kai Zhang · 3 shared papers, 2017–2026 · strength 0.47
  14. Chunhua Xi · 5 shared papers, 2017–2022 · strength 0.47
  15. Kai Zhang · 4 shared papers, 2019–2022 · strength 0.45
  16. Zekuan Xu · 8 shared papers, 2011–2025 · strength 0.44
  17. Kuirong Jiang · 3 shared papers, 2013–2025 · strength 0.43
  18. Dong Xu · 3 shared papers, 2020–2023 · strength 0.43
  19. Yi Miao · 5 shared papers, 2013–2025 · strength 0.37
  20. Kai Lin · 2 shared papers, 2021–2023 · strength 0.37
  21. Xumin Huang · 2 shared papers, 2020–2026 · strength 0.34
  22. Zhuyin Qian · 5 shared papers, 2011–2025 · strength 0.33
  23. Chuang Yang · 2 shared papers, 2017–2025 · strength 0.33
  24. Qiang Li · 5 shared papers, 2011–2022 · strength 0.32
  25. Jian‐Min Chen · 2 shared papers, 2022–2025 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.